Promoter shareholding decreased by 1.65% YoY, while sector averages remained unchanged, indicating a divergence and negative sentiment for Vineet Laboratories.

Public shareholding declined by 2.98% YoY and 1.81% QoQ, contrasting with stable sector public participation, suggesting potential loss of confidence among retail investors.

In a sector where institutions are actively investing in top performers like SANOFICONR, Vineet Laboratories appears to lag significantly, reflecting a broader trend of selling rather than buying.